Sanofi

$49.08
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.71 (-1.42%) Today
-$0.09 (-0.18%) As of 8:20 AM EDT after-hours

Why Robinhood?

You can watch Sanofi and buy or sell other stocks, options, and ETFs commission-free!

About SNY

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. Read More The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes and cardiovascular, established prescription products and generics, and research, development, and production activities. The Consumer Healthcare segment includes the commercial operations for its Consumer Healthcare products. The Vaccines segment consists commercial operations of Sanofi Pasteur. The company was founded in 1973 and is headquartered in Paris, France. The listed name for SNY is Sanofi ADR.

Employees
100,409
Headquarters
Paris, Ile-de-France
Founded
1973
Market Cap
123.55B
Price-Earnings Ratio
10.17
Dividend Yield
2.35
Average Volume
1.11M
High Today
$50.03
Low Today
$49.17
Open Price
$49.76
Volume
1.44M
52 Week High
$55.00
52 Week Low
$37.62

Collections

SNY News

ReutersOct 15

Sanofi reports positive animal test results for potential COVID-19 vaccine

PARIS (Reuters) - Clinical trials of an experimental vaccine against COVID-19 which is being developed by France’s Sanofi and U.S. biotech firm Translate Bio ar

SNY Earnings

$0.00
$0.70
$1.39
$2.09
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Estimated
per share
Actual
Available Oct 29, Pre-Market

You May Also Like